Alembic Pharmaceuticals gained 3.99% to Rs 1,027 after the company said its qualified institutions placement (QIP) issue to raise Rs 1,000 crore opened on 3 August 2020.
The floor price of the QIP issue is Rs 980.75 per equity share. The company's board will meet on 5 August 2020 to approve the issue price.
The fund-raising board of Alembic Pharmaceuticals on 27 July had given an approval to raise Rs 1000 crore through a QIP.
Alembic Pharmaceuticals reported a 143.7% surge in consolidated net profit to Rs 301.46 crore on 41.4% rise in net sales to Rs 1,341.32 crore in Q1 June 2020 over Q1 June 2019.
Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
